TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Elon Musk Says Tesla Cybercab and Optimus Production Will Start Slowly Before Rapid Growth 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
Microsoft Restores Microsoft 365 Services After Widespread Outage 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure 
South Korea Seeks Favorable U.S. Tariff Terms on Memory Chip Imports 
Facebook Founder Mark Zuckerberg and wife Priscilla Chan recently acquired the artificial intelligence startup called Meta for their charity group, the Chan Zuckerberg Initiative. The couple also has plans to make it free in the future so that scientists could have access to the technology produced by the company without having to pay.
Meta is an AI startup that largely focuses on developing machine data analytics for sifting through mountains of medical research papers, Fortune reports. The implications of such a technology for boosting the ability of medical professionals to get data on the latest findings is staggering, which is exactly why the Zuckerberg and Chan decided to get the startup.
This isn’t the only company that’s betting on the ability of AIs to significantly reduce the amount of time to process and presents information to researchers either. IBM and Watson are also invested in the field because they believe, as does the Chan Zuckerberg Initiative that advanced machine analytics is where the future of research is at.
In a blog post that Meta’s CEO Sam Molyneux wrote about the development, he noted how becoming part of the charity organization will significantly boost their interaction and options for contact with medical professionals than when it was just a startup. Considering what the company was trying to achieve in the first place, this is exactly in line with what it was going for.
“Through open solicitations, convenings, joint projects and grants, we will embrace the ideas and efforts of researchers in the diverse fields that Meta intersects with – including machine learning, network science, ontologies, science metrics, and data visualization,” the post reads.
After several months of refining the technology, the organization also plans on making it freely accessible to researchers, TechCrunch reports. Meta’s prospects basically revolve around removing some of the biggest obstacles in scientific advancements, which are money and digesting an insurmountable amount of data.
